Dividend Capture Strategy: 15 High Yield Stocks to Buy in April
Dividend investing appears to be a simple strategy on the surface, but in reality, it requires a much deeper analysis.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 19,610,579 | $880,318,891 | +50% | 2.99% |
| 2. | Glenview Capital Larry Robbins | 11,946,799 | $536,291,807 | 13.55% | |
| 3. | Citadel Investment Group Ken Griffin | 6,366,445 | $285,789,716 | +195% | 0.04% |
| 4. | Harris Associates Natixis Global Asset Management | 5,707,675 | $256,217,513 | -1% | 0.33% |
| 5. | 5,019,000 | $225,302,910 | -35% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.70 | 30,000 | Director | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | Director | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | Director | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | Director | 20,630 | 2023-11-03 | Filing | |
| $69.75 | 14,000 | Officer, Director | 431,392 | 2023-05-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.35 | 7,513 | Officer | 8,394 | 2025-03-05 | Filing | |
| $76.95 | 29,473 | Officer | 39,765 | 2024-02-16 | Filing | |
| $74.94 | 23,128 | Officer | 4,698 | 2023-08-03 | Filing | |
| $74.79 | 2,631 | Officer | 27,826 | 2023-08-03 | Filing | |
| $98.24 | 36,490 | Officer | 608,129 | 2022-12-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 410,360 | $27,551,570 | 2.13% | |
| 2. | 16,597 | $1,124,449 | 0.17% | |
| 3. | 4,719 | $319,712 | 0.01% | |
| 4. | 4,500 | $304,875 | 0.23% | |
| 5. | 1,073 | $48,171 | 0.02% |
News See All
Here’s What Dragged CVS Health Corp. (CVS) in Q4
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Jim Cramer Looked At These 23 Stocks Recently
Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street.
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
11 Oversold Blue Chip Stocks to Buy According to Hedge Funds
The uncertainty related to the tariff announcements continues to influence Wall Street.
Stocks On the Rise: 10 Best Stocks to Buy Right Now
As per Merrill Lynch, 2025 has not shown much movement. Between the US tariffs and trade wars, geopolitical scenarios, and more, investors continue to be surrounded by attention-grabbing headlines.
Top 10 Health Insurance Stocks To Buy
The health insurance industry is constantly changing, driven by a movement towards consumer-driven healthcare, in which people actively control their own health and healthcare costs.
Do You Believe in the Growth Prospects of CVS Health Corporation (CVS)?
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Performing Healthcare Stocks So Far in 2025
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Billionaire Hedge Funds
